Tabula Rasa HealthCare (TRHC) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tabula Rasa HealthCare Announces Second Quarter 2017 Results
August 7, 2017 4:15 PM EDTMOORESTOWN, N.J., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools, today announced its financial results for the second quarter ended June 30, 2017.
This was another very strong quarter for Tabula Rasa HealthCare, with both revenue and Adjusted EBITDA coming in above forecast, said Calvin H. Knowlton, PhD, TRHCs Chairman and Chief Executive Officer. We are seeing increased interest in TRHCs disruptive offerings as awareness that a... More
